Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 95%
filed 2026-09-25
Item 2.02
This is a clear earnings release disclosing Astrotech's financial results for the fiscal year ended June 30, 2026. The press release (Exhibit 99.1) presents consolidated statements of operations showing a net loss of $14.4 million and a consolidated balance sheet as of June 30, 2026, along with comparative prior-year figures. The filing explicitly states the Company "issued a press release announcing its results of operations for the quarter and year ended June 30, 2026," which is the hallmark of an earnings_release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-25
Item 2.02
This is a straightforward earnings release disclosing quarterly and fiscal year financial results for the period ended June 30, 2026. The press release (Exhibit 99.1) presents condensed consolidated statements of operations showing revenue decline of 19.3% year-over-year, a swing from operating income of $2.0 million to an operating loss of $2.7 million, and a net loss of $2.8 million versus prior-year net income of $0.8 million. The disclosure is material as it reflects significant deterioration in financial performance and would affect a reasonable investor's assessment of the company.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-25
Item 2.02
Tamboran Resources issued an earnings presentation and press release on September 25, 2026, announcing financial and operating results for the quarter ended June 30, 2026. The Item 2.02 disclosure explicitly states that "Tamboran Resources Corporation issued an earnings presentation and press release announcing its financial and operating results," with exhibits 99.1 and 99.2 attached. The presentation includes quarterly highlights, cash position, capital structure, and operational metrics—all hallmarks of a quarterly earnings release.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-24
Item 2.02
Scholastic Corporation issued a press release on September 24, 2026 announcing its fiscal 2027 first quarter results for the period ended August 31, 2026. The disclosure includes detailed financial statements, segment results, revenue and operating loss figures, and forward guidance affirming fiscal 2027 revenue growth of 2-4% and Adjusted EBITDA of $135-145 million. This is a standard quarterly earnings release material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-09-24
Item 2.02
Costco disclosed its operating results for the 16-week fourth quarter and 52-week fiscal year ended August 30, 2026, via a press release attached as Exhibit 99.1. The disclosure includes consolidated statements of income, balance sheets, and cash flows showing net sales of $93.9 billion (Q4) and $297.2 billion (FY), net income of $2.998 billion (Q4) and $9.226 billion (FY), and diluted EPS of $6.75 (Q4) and $20.76 (FY). This is a standard quarterly/annual earnings release material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-24
Item 2.02
This is a clear earnings release for Darden Restaurants' fiscal 2027 first quarter ended August 30, 2026. The Item 2.02 disclosure includes a news release titled "Darden Restaurants Reports Fiscal 2027 First Quarter Results" with detailed financial statements (consolidated statements of earnings, balance sheets, and cash flows), segment performance data, and forward guidance reaffirmation. The exhibit (EX-99.1) contains the full press release with quarterly financial highlights, same-restaurant sales metrics, diluted EPS of $2.05, and segment profit details—all hallmarks of a quarterly earnings disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-24
Item 2.02
BlackBerry issued a press release on September 24, 2026 announcing financial results for the quarter ended August 31, 2026, disclosing revenue of $163.3 million (26% YoY growth), adjusted EBITDA of $47.0 million (81% YoY growth), positive GAAP net income of $33.9 million for the sixth consecutive quarter, and raised fiscal year 2027 guidance. This is a standard quarterly earnings release with detailed financial statements and forward guidance, clearly falling under Item 2.02 Results of Operations and Financial Condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-24
Item 2.02
This is a clear earnings release disclosing Rezolute's financial results for the fourth quarter and full fiscal year ended June 30, 2026. The Item 2.02 disclosure explicitly states the company "issued a press release announcing its financial results" with condensed consolidated financial statements showing R&D expenses, G&A expenses, net loss, and balance sheet data. The press release is attached as Exhibit 99.1 and includes both financial results and a business update on clinical trial progress.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-24
Item 2.02
This is a straightforward earnings release disclosing RAVE Restaurant Group's fourth quarter and fiscal year 2026 financial results. The press release, attached as Exhibit 99.1, reports net income of $2.9 million for fiscal 2026 (up from $2.7 million in 2025), total revenue of $12.9 million, and pre-tax income of $3.9 million—described as the highest pre-tax profitability in 23 years. The disclosure includes detailed quarterly and annual highlights, consolidated financial statements, and cash flow analysis, all typical of a material earnings announcement under Item 2.02.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-24
EX-99.1
This is a press release announcing QTREX's first half 2026 financial results for the six months ended June 30, 2026. The exhibit discloses revenue of $1.55 million (up 438% year-over-year), gross margin of 61%, operating loss of $6.9 million, and net loss of $6.4 million per share, along with detailed financial statements and business highlights. The disclosure is material as it reports the company's first significant revenue generation following its April 2026 acquisition of the AME platform and provides forward guidance for Q4 2026 and 2027.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-24
EX-99.3
This exhibit is a press release announcing YYForce's unaudited financial results for the six months ended June 30, 2026. It discloses revenue of US$32.7 million (26.8% YoY growth), net loss of US$7.06 million (13.8% narrower YoY), and includes detailed operational metrics, management commentary, and forward-looking guidance. The document explicitly states "YYForce Issues First Half 2026 Financial Results" and includes condensed consolidated financial statements, making it a classic interim earnings release material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-09-24
Item 7.01
Stifel issued a press release on September 24, 2026, disclosing selected operating results for August 31, 2026, including key performance metrics such as total client assets ($587.6B), fee-based client assets ($244.4B), treasury deposits, and bank loans. The CEO commentary provides forward guidance on Q3 2026 net revenue expectations. Although labeled Item 7.01, the filing explicitly references Item 2.02 and furnishes a press release with financial operating data and management commentary, which is the hallmark of an earnings or results disclosure.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-24
EX-99.1
This is a press release announcing Pasqal's first half 2026 financial results, dated September 24, 2026. It discloses revenue of €4.9 million (14% YoY growth), operating loss of €59.2 million, cash position of €110.8 million as of June 30, 2026, and includes condensed consolidated financial statements (balance sheet, P&L, and cash flows). The document explicitly states "Pasqal Reports First Half 2026 Financial Results" and includes detailed financial highlights and business metrics. This is a discrete earnings announcement, not a periodic financial report filing itself, and is material to investors assessing the registrant's financial performance and operational progress.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-09-24
EX-99.3
This is a press release disclosing TurboGen's first-half 2026 financial results, including revenue (none), operating loss ($5.2M), net loss ($4.2M), cash position ($7.2M), and shareholders' equity ($1.6M). Although the company is development-stage and pre-revenue, the structured presentation of interim financial results with year-over-year comparisons and business highlights is characteristic of an earnings release. The filing also discloses a material subsequent $5M private placement and Nasdaq listing on August 31, 2026, which are significant corporate events affecting investor assessment.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-24
EX-99.3
This is a press release announcing INLIF's unaudited financial results for the first half of fiscal year 2026 ended June 30, 2026. The exhibit discloses key financial metrics including net revenue of $12.94 million (26.01% increase), gross profit of $4.65 million (158.77% increase), and net income of $1.01 million versus a prior-year net loss of $1.98 million. The filing includes detailed financial statements (balance sheet, income statement, cash flow statement) and management commentary from the CEO. This is a material earnings disclosure that would affect a reasonable investor's assessment of the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-24
Item 2.02
H.B. Fuller Company announced its third quarter 2026 operating results on September 23, 2026, disclosing net revenue of $938 million (up 5.2% YoY), net income of $79 million, adjusted EBITDA of $187 million (up 9% YoY), and adjusted diluted EPS of $1.52 (up 21% YoY). The press release is furnished as Exhibit 99.1 and includes detailed financial statements, segment performance, balance sheet metrics, and updated fiscal 2026 guidance. This is a standard quarterly earnings release under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-24
Item 2.02
This is a clear earnings release for Trio-Tech International's fiscal year and fourth quarter ended June 30, 2026. The press release (Exhibit 99.1) discloses comprehensive financial results including revenue of $62.6 million (72% growth), gross profit, operating results, and earnings per share, along with forward-looking guidance and backlog information. The Item 2.02 disclosure explicitly states the company "issued a press release announcing its financial results for the fiscal quarter ended June 30, 2026," which is the hallmark of an earnings_release event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-24
Item 2.02
ICF International announced the timing and details of its third quarter 2026 earnings release scheduled for November 5, 2026, after market close, along with a webcast conference call. The press release (Exhibit 99.1) explicitly states "ICF...will release its third quarter 2026 results on Thursday, November 5, 2026, after the market close" and provides registration and access details for the earnings call. This is a standard earnings announcement disclosure under Item 2.02.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-24
EX-99.1
This exhibit is a press release announcing Uxin's unaudited financial results for the quarter ended June 30, 2026. It discloses quarterly revenue (RMB1,151.2 million), gross margin (-0.7%), operating loss (RMB151.9 million), and net loss (RMB178.4 million), along with transaction volumes and forward guidance. The document explicitly states "Uxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2026" and includes management commentary on performance. This is a discrete earnings announcement, not a periodic financial report filing itself.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-24
The 8-K discloses fiscal year 2026 financial results for AtlasClear Holdings via a press release dated September 23, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The filing reports significant metrics including 85% revenue growth to $20.1 million, positive GAAP net income of $2.0 million for the second consecutive year, cash doubling to $15.4 million, and resolution of going-concern doubts. This is a material earnings disclosure affecting investor assessment of the registrant's financial performance and condition.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-24
Item 2.02
TD SYNNEX issued a press release on September 24, 2026 disclosing financial results for fiscal Q3 2026 ended August 31, 2026, including revenue of $21.6 billion (up 37.7% YoY), operating income of $643 million (up 67.6% YoY), and diluted EPS of $5.18 (up 89.1% YoY). The filing also announces a quarterly dividend of $0.48 per share. This is a standard quarterly earnings release with material financial results that would affect a reasonable investor's assessment of the company's performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-23
Item 2.02
Cintas Corporation issued a press release on September 23, 2026, announcing its fiscal 2027 first quarter financial results for the period ended August 31, 2026. The disclosure includes detailed revenue ($3.01 billion, up 10.9%), gross margin (51.5%, up 120 basis points), operating income ($711.9 million, up 15.2%), net income ($551.7 million, up 12.3%), and diluted EPS ($1.36, up 13.3%), along with updated full-year fiscal 2027 guidance. This is a standard quarterly earnings release furnished as Exhibit 99 under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-09-23
Item 2.02
Paychex issued a press release on September 23, 2026 reporting financial results for the three months ended August 31, 2026 (first quarter fiscal 2027). The disclosure includes consolidated statements of income, balance sheets, revenue growth metrics (6% total revenue growth to $1.6 billion, 14% operating income growth, 14% diluted EPS growth), and updated fiscal 2027 guidance. This is a standard quarterly earnings release furnished under Item 2.02.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-09-23
EX-99.1
This is a corporate press release announcing Manchester United's fourth quarter and full-year fiscal 2026 financial results, dated 23 September 2026. The exhibit discloses record full-year revenue of £677.6 million, adjusted EBITDA of £216.4 million, and a net loss of £43.0 million, along with detailed revenue analysis by segment (Commercial, Broadcasting, Matchday) and forward guidance for fiscal 2027. This is a classic earnings release event material to investors assessing the registrant's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-23
Item 2.02
This is a clear earnings release disclosing Cracker Barrel's fourth quarter and full-year fiscal 2026 financial results, including revenue ($849.3M for Q4, $3.32B for full year), net income ($12.2M for Q4, $31.7M for full year), and earnings per share ($0.54 diluted for Q4, $1.40 for full year), along with fiscal 2027 outlook. The press release is furnished as Exhibit 99.1 and is the primary disclosure under Item 2.02.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-23
EX-99.1
This exhibit is a press release announcing Robin Energy Ltd.'s financial results for Q2 2026 and the first half of 2026. It discloses net income of $5.6 million for Q2 and $6.1 million for H1 2026, with detailed revenue, expense, and operational metrics. The document explicitly states "Robin Energy Ltd. Reports Net Income of $5.6 Million for the Three Months Ended June 30, 2026" and includes comprehensive financial tables and management commentary on earnings performance—the hallmark of an earnings release event.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-09-23
EX-99.1
This is a profit alert press release announcing preliminary financial guidance for the full year ending December 31, 2026. The Company discloses an expected net profit increase of no less than 100% compared to the prior year, driven by revenue growth from premium wine sales, operational efficiency gains, and vertical integration efforts. Although labeled a "profit alert" rather than final results, this forward-looking earnings guidance is material to investors and is the substance of the disclosure.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-23
EX-99.3
This is a press release announcing unaudited interim financial results for the first half of 2026 (ended June 30, 2026), with accompanying condensed consolidated financial statements (income statement, balance sheet, cash flows) and non-IFRS reconciliations. The document explicitly states "Guardforce AI Reports Interim Financial Results for the First Half of 2026" and discloses revenue growth of 6.4%, operational metrics, and a net loss of $3.1 million. This is a discrete earnings announcement, not a periodic financial report filing itself, and would materially affect a reasonable investor's assessment of the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-23
The 8-K discloses preliminary unaudited financial results for fiscal year ended June 30, 2026 via a press release (Exhibit 99.1) filed under Item 2.02. The filing reports significant metrics including 85% revenue growth to $20.1 million, second consecutive year of positive net income (~$2.0 million), cash more than doubling to $15.4 million, and stockholders' equity of $21.1 million (versus prior-year deficit). These preliminary results are material to investors assessing the registrant's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-23
Item 2.02
General Mills issued a press release on September 23, 2026, reporting financial results for its first quarter ended August 30, 2026, disclosing net sales of $4.4 billion (down 3%), operating profit of $634 million (down 63%), and diluted EPS of $0.74 (down 67%), along with reaffirmed full-year fiscal 2027 guidance. This is a standard quarterly earnings release filed under Item 2.02 with the press release attached as Exhibit 99.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-23
Item 2.02
Stitch Fix announced its financial results for the fourth quarter and full fiscal year 2026 ended August 1, 2026, including net revenue of $1,348.1 million (6.4% YoY growth), net loss of $12.6 million, and forward guidance for fiscal 2027 projecting revenue of $1.310–$1.360 billion. The press release is furnished as Exhibit 99.1 and includes consolidated financial statements, cash flow data, and management commentary from CEO Matt Baer. This is a standard quarterly/annual earnings disclosure under Item 2.02.
View raw filing on EDGAR →
6-K
Earnings release
confidence 75%
filed 2026-09-23
EX-99.1
This is a press release announcing positive clinical trial results for ACI-7104 in the VacSYn Phase 2 trial. While not a financial earnings release, it discloses material clinical trial outcomes (all primary endpoints met, 100% immunogenicity response rate, CSF antibody penetration, target engagement signals) that would significantly affect investor assessment of the company's lead program and development trajectory. The disclosure of clinical milestones and regulatory pathway discussions is material to a biopharmaceutical company's valuation and prospects.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-23
Item 2.02
NeoVolta issued a press release on September 23, 2026, announcing financial results for the fourth quarter and fiscal year ended June 30, 2026. The disclosure includes detailed financial highlights (58% year-over-year revenue growth to $13.3 million, GAAP net loss of $21.5 million, and Adjusted EBITDA of $(12.8) million), consolidated balance sheets, statements of operations, and cash flow statements. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and operational trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-22
Item 2.02
MillerKnoll issued a press release on September 22, 2026, announcing financial results for the first quarter of fiscal 2027 ended August 29, 2026. The disclosure includes detailed quarterly financial statements (condensed consolidated statements of operations, cash flows, and balance sheets), segment results, guidance for Q2 and full year FY2027, and management commentary from the Interim CEO. This is a standard quarterly earnings release attached as Exhibit 99.1 to Item 2.02, which is material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-22
Item 2.02
THOR Industries issued a press release on September 22, 2026 announcing financial results for the fourth quarter and full year ended July 31, 2026, reporting consolidated net sales of $9.61 billion, net income of $177.5 million, and diluted EPS of $3.38, along with detailed segment results and management commentary.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-22
Item 2.02
KB Home issued a press release on September 22, 2026, announcing third quarter and nine-month financial results for the period ended August 31, 2026, including revenues of $1.30 billion, diluted EPS of $1.05, and detailed operating metrics. The disclosure is a standard quarterly earnings announcement with consolidated financial statements, balance sheet data, and forward guidance, filed under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-09-22
Item 7.01
NN, Inc. issued a press release on September 22, 2026 announcing raised full-year 2026 guidance for Net Sales ($470–$490M, up from $460–$480M) and Adjusted EBITDA ($58–$68M, up from $55–$65M), accompanied by an investor presentation for the D.A. Davidson conference. While technically a guidance update rather than reported results, the press release and presentation constitute a material earnings-related disclosure that would affect investor assessment of the company's financial performance and outlook. The disclosure includes detailed financial metrics, segment performance, and forward-looking guidance comparable to an earnings announcement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-09-22
Item 8.01
Celldex announced positive Phase 3 trial results for barzolvolimab in chronic spontaneous urticaria (CSU), meeting primary and all key secondary endpoints. While this is technically a clinical trial result rather than financial earnings, it is disclosed via press release in Item 8.01 and represents a material milestone that would significantly affect investor assessment of the company's pipeline value and regulatory prospects. The announcement of successful Phase 3 data supporting a planned 2027 BLA submission is a transformational event for a clinical-stage biopharmaceutical company.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-09-22
Item 2.02
AutoZone issued a press release on September 22, 2026, announcing its fourth quarter and fiscal year 2026 earnings results, including net sales of $6.6 billion for Q4 and $20.3 billion for the full year, diluted EPS of $56.05 for Q4 and $152.55 for the year, and net income of $931.6 million and $2.6 billion respectively. This is a standard earnings release disclosure under Item 2.02, with detailed financial statements and operational metrics attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-09-22
Item 8.01
Viking Therapeutics announced positive top-line results from a clinical maintenance study of its lead candidate VK2735, a GLP-1/GIP agonist. The press release discloses detailed efficacy and safety data from a Phase 2 maintenance study, including weight loss percentages, maintenance rates across dosing regimens, and adverse event profiles. This constitutes a material clinical trial result disclosure that would significantly affect investor assessment of the company's pipeline and commercial prospects for its obesity treatment candidate.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-22
Item 2.02
Worthington Enterprises issued a news release reporting fiscal 2027 first quarter results for the three-month period ended August 31, 2026, with net sales of $343.9 million (up 13%), net earnings of $42.6 million (up 22%), and EPS of $0.87.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-09-22
EX-99.1
This is a press release announcing unaudited financial results for the fourth quarter and full fiscal year 2026 (ended June 30, 2026), including revenues of RMB596.8 million for FY 2026 and a net loss from continuing operations of RMB254.9 million. The document explicitly states "Here Announces Unaudited Financial Results for the Fourth Quarter and Full Fiscal Year 2026" and provides detailed quarterly and annual financial metrics. While the exhibit also discloses an executive departure (Ms. Liu Xihao's resignation), the primary and dominant disclosure is the earnings announcement, making this an earnings_release. The material impairment charge of RMB124.1 million is disclosed as part of the earnings results, not as a separate impairment event.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-22
EX-99.3
This is a press release disclosing HUHUTECH's financial results for the first half of 2026, including revenue of $10.67 million (8.6% growth), net loss of $16.65 million, and key operational metrics. The document explicitly states "HUHUTECH Reports 8.6% Revenue Growth for First Half of 2026" and includes unaudited condensed consolidated financial statements (balance sheet, statements of operations, and cash flows). This is a discrete earnings announcement, not a periodic financial report filing, and would materially affect a reasonable investor's assessment of the company's financial performance and geographic expansion strategy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-22
Item 2.02
The filing discloses Aytu BioPharma's fiscal 2026 fourth quarter and full-year operational and financial results via a press release (Exhibit 99.1). The disclosure includes detailed revenue figures by product portfolio, gross profit, operating expenses, net loss, Adjusted EBITDA, and cash position—all standard components of an earnings release. The company explicitly scheduled a conference call for September 22, 2026, to discuss these results, which is typical for earnings announcements.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-21
Item 2.02
This is a clear earnings release disclosing financial results for the fiscal year and fourth quarter ended June 30, 2026. The press release, furnished as Exhibit 99.1, presents comprehensive financial statements including revenues ($48.1M vs. $48.4M prior year), net loss ($11.2M vs. $2.6M prior year), and adjusted EBITDA (loss of $0.5M vs. profit of $2.0M prior year), along with detailed operational commentary. The filing explicitly states "Bloomia Holdings, Inc. (the 'Company') issued a press release announcing the Company's financial results" under Item 2.02, which is the standard Item for earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-21
Item 2.02
Ennis, Inc. issued a press release on September 21, 2026 announcing financial results for the three and six months ended August 31, 2026, including revenues of $102.0 million for the quarter, net earnings of $9.4 million, and diluted EPS of $0.37.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-21
Item 2.02
AnaptysBio issued a press release on September 21, 2026, announcing financial results for the three months and transitional fiscal year ended June 30, 2026. The disclosure includes consolidated balance sheets, statements of operations, and comprehensive loss data, along with key financial metrics such as collaboration revenue of $27.5 million and $53.0 million for the three and six months ended June 30, 2026, and net income from continuing operations of $177.3 million and $176.4 million respectively. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the registrant's financial performance and royalty-generating capacity from its Jemperli and Quimilza collaborations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-21
Item 2.02
The 8-K Item 2.02 discloses Marygold Companies' financial results for fiscal year and fourth quarter ended June 30, 2026, furnished as an earnings press release (Exhibit 99.1 dated September 18, 2026). The press release reports revenue growth of 8% to $25.3 million, narrowed net loss to $4.4 million, and includes consolidated statements of operations and balance sheets. This is a standard earnings release disclosure material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-21
EX-99.15
CordovaCann released annual financial results for fiscal year ended June 30, 2022, disclosing $13.5 million in revenues (31% growth year-over-year) and improved net loss per share of (0.04) versus (0.06) in the prior year.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-09-21
EX-99.21
CordovaCann released annual consolidated financial statements for fiscal year ended June 30, 2021, disclosing revenues of $10.3 million (versus $0.2 million prior year) and net loss per share of (0.06) (versus (0.10) prior year), with operational updates on Star Buds Cannabis Co. retail performance.
View raw filing on EDGAR →